Share this post on:

Product Name :
Tirzepatide

Search keywords :
GLP-1R

drugId :
null

Target Vo:
Glucagon-like peptide 1 receptor

Target Vo Short Name :
GLP1R

Moa_Name:
Glucagon-like peptide 1 receptor agonists

First Approval Country :
United States

First Approval Date Filter:
2022

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
BioAge Labs Inc

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:
Endocrine System Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Parkin Rabbit pAb Purity & Documentation
Caspase-6 Rabbit mAb custom synthesis
Integrin beta 1 Antibody: Integrin beta 1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 88 kDa, targeting to Integrin beta 1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related